Michal Abrahamowicz Selected Research

Flurazepam (Dalmane)

4/2012	Assessing the cumulative effects of exposure to selected benzodiazepines on the risk of fall-related injuries in the elderly.
4/2006	Modeling cumulative dose and exposure duration provided insights regarding the associations between benzodiazepines and injuries.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michal Abrahamowicz Research Topics

Disease

16	Rheumatoid Arthritis 07/2022 - 06/2005
9	Myocardial Infarction 01/2018 - 02/2002
7	Infections 10/2021 - 08/2008
7	Heart Failure 05/2020 - 02/2007
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 02/2008
5	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2012
5	Neoplasms (Cancer) 01/2021 - 01/2012
4	Wounds and Injuries (Trauma) 10/2021 - 04/2006
4	Atrial Fibrillation 05/2020 - 11/2004
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 09/2008
4	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2018
3	Hepatitis C 06/2019 - 03/2014
3	Coronary Disease (Coronary Heart Disease) 01/2019 - 02/2008
3	Stroke (Strokes) 01/2019 - 06/2011
3	Pain (Aches) 06/2013 - 09/2003
2	Urinary Incontinence 01/2021 - 11/2017
2	Hypoglycemia (Reactive Hypoglycemia) 01/2019 - 01/2018
2	Stillbirth 01/2019 - 01/2012
2	Inflammation (Inflammations) 01/2019 - 01/2012
2	Spontaneous Abortion (Miscarriage) 01/2019 - 01/2016
2	Hypertension (High Blood Pressure) 10/2017 - 11/2015
2	Obesity 11/2016 - 01/2016
2	Diabetes Mellitus 11/2016 - 01/2016
2	Alcoholism (Alcohol Abuse) 09/2015 - 01/2009
2	Psychotic Disorders (Schizoaffective Disorder) 09/2013 - 10/2012
2	Cognitive Dysfunction 08/2011 - 09/2002
2	Prostatic Neoplasms (Prostate Cancer) 08/2010 - 12/2008
1	Pneumonia (Pneumonitis) 08/2021
1	Human Influenza (Influenza) 08/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Rectal Neoplasms (Rectal Cancer) 01/2021
1	COVID-19 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Weight Gain 01/2020
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Fibrosis (Cirrhosis) 06/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2019
1	Drug-Related Side Effects and Adverse Reactions 01/2019
1	Mycoses (Diseases, Fungus) 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2018

Drug/Important Bio-Agent (IBA)

12	Pharmaceutical PreparationsIBA 01/2022 - 06/2007
6	GlucocorticoidsIBA 01/2020 - 06/2011
5	Antirheumatic Agents (DMARD)IBA 07/2022 - 08/2008
5	Antidepressive Agents (Antidepressants)IBA 02/2017 - 09/2008
4	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 08/2008
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2012 - 04/2005
3	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 01/2018
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2017 - 07/2004
3	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2015 - 02/2008
3	BenzodiazepinesIBA 04/2012 - 04/2006
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 01/2022
2	antineoplaston A10 (A 10)IBA 01/2022 - 09/2003
2	VaccinesIBA 08/2021 - 07/2003
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2020
2	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 10/2017
2	tyramine-deoxysorbitolIBA 10/2017 - 11/2015
2	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 10/2017 - 11/2015
2	ORALIT (ORS)IBA 01/2017 - 10/2012
2	CarcinogensIBA 01/2017 - 11/2016
2	Biological ProductsIBA 11/2016 - 12/2011
2	Biomarkers (Surrogate Marker)IBA 08/2014 - 03/2009
2	Flurazepam (Dalmane)FDA LinkGeneric 04/2012 - 04/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2011 - 08/2008
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 05/2008 - 07/2004
1	Bevacizumab (Avastin)FDA Link 01/2021
1	chemotactic factor inactivatorIBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	pembrolizumabIBA 01/2020
1	SodiumIBA 01/2020
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2020
1	NivolumabIBA 01/2020
1	IpilimumabIBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	InterferonsIBA 06/2019
1	Antiviral Agents (Antivirals)IBA 06/2019
1	AzolesIBA 01/2019
1	insulin receptor-related receptor (IRR)IBA 01/2019
1	Fluconazole (Zonal)FDA LinkGeneric 01/2019
1	C-Reactive ProteinIBA 01/2019
1	Tumor Necrosis Factor InhibitorsIBA 10/2018
1	LipidsIBA 10/2018
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018
1	Isophane Insulin (NPH Insulin)FDA Link 01/2018
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018
1	Protamines (Protamine Sulfate)FDA Link 01/2018
1	Janus Kinase InhibitorsIBA 01/2018

Therapy/Procedure

13	Therapeutics 01/2022 - 02/2011
4	Secondary Prevention 02/2011 - 02/2002
3	Catheter Ablation 05/2020 - 12/2019
2	Radiotherapy 02/2017 - 12/2008
2	Replacement Arthroplasty 01/2016 - 08/2015
2	Ambulatory Care (Outpatient Care) 02/2011 - 02/2008
2	Brachytherapy 08/2010 - 12/2008
1	Biological Therapy 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021
1	Patient Readmission 01/2020
1	Medication Reconciliation 01/2019